15 June 2013
Product labelling for naloxone solution for injection 400µg/ml has been updated to include “infusion” in the product name. Medical and further information on 01452 621661.
Similac Alimentum will now be known as Alimentum. All other product details are unaffected. Net price 1 x 400g tin, £9.10.
25 May 2013
Piriton (chlorphenamine; GSK) tablets 4mg x 500, currently supplied by GSK Consumer Healthcare, will be supplied by GSK UK Pharma from 1 June 2013. Further information on 0800 221 441.
Rosemont liquid specials
Rosemont Pharmaceuticals has announced that its specials range of liquid medicines will now
come packaged in cartons with a patient information leaflet included in the pack. The repackaged liquid medicines will be introduced into the market once the previous batches have been used. Further information on 0113 244 1999.
04 May 2013
Premarin (conjugated eostrogens; Pfizer) tablets 1.25mg now have a new formulation. The new tablets are bioequivalent but appear slightly larger than the previous tablets. Net price is 6 x 14, £3.58. Further information on 0845 608 8866.
27 April 2013
Subsequent to Actavis’s acquisition of Arrow last year, several Arrow products are now available through the Actavis product portfolio.
13 April 2013
Byetta and Bydureon
The Bristol-Myers Squibb/ AstraZeneca alliance has acquired the marketing authorisations for Byetta (exenatide) and Bydureon (exenatide prolonged release) from Lilly. Further information on 0800 731 1736.
HumaPen SAVVIO, a new insulin delivery device designed to be more discreet, is now available from Lilly. Further information on 01256 315000. Net price, 1 x pen, £26.82.
16 March 2013
Codipar Caplets (codeine phosphate 15mg/paracetamol 500mg; Mercury Pharma) are now called Codipar Tablets. Further information on 020 8588 9441. Medical information on 08700 703033.
Neokay (phytomenadione; Neoceuticals) drops 200µg/ml are now distributed by M&A PharmaChem. The product was previously available from Mawdsleys. Further information on 01748 828865.
16 February 2013
Intrinsa (testosterone) transdermal patch 300µg is currently being supplied as an unlicensed medicine by HFA Healthcare following a decision by Warners Chilcott to cancel the marketing authorisation for commercial reasons. HFA has secured the manufacture of further batches and is now in discussion with the European regulatory authorities to relicense Intrinsa. It is expected that this process will take around 12 months.
09 February 2013
Midrid capsules (paracetamol 325mg and isometheptene mucate 65mg) in packs of 15 and 30 are now available from DHP Healthcare and distributed by Movianto. This product is no longer available from Manx Healthcare. More information on 01622 749222, distribution information on 01234 248500.
The administration device for Ursofalk (ursodeoxycholic acid; Dr Falk) suspension 250mg/5ml has changed. The pack now contains a 5ml graduated cup for measuring and administering the suspension.
26 January 2013
Utrogestan and oestrogel
Marlborough Pharmaceuticals is the new supplier of Utrogestan (progesterone) capsules 100mg and 200mg and Oestrogel (estradiol) 0.06 per cent w/w 80g pump pack. Marlborough will be distributing these products through UniDrug Distribution Group. More information on 01672 514187.
19 January 2013
Loratadine and loperamide
The pack size of loratadine tablets 10mg available on the general sale list has increased from 14 to 20. In addition, the maximum pack size of loperamide tablets 2mg, available on the general sale list, has been increased from six to 12.
Novartis is switching from Becton & Dickinson to B. Braun as supplier of the injection needle provided in packs of Lucentis (ranibizumab). A difference in appearance of the injection needle and its outer packaging may be noticed. There will be no other changes to the Lucentis pack.
22-29 December 2012
Flo-Tone Trainer is now available from Clement Clarke International. It is an add-on to a pressurised inhaler used to help patients acquire good inhaler technique. Price 10 x Flo-Tone Trainer, £18.87.
Pfizer is introducing a “needle trap” safety device to Fragmin (dalteparin sodium) prefilled syringes with effect from 14 January 2013. The needle-trap equipped Fragmin syringes will be phased into the supply chain over a four-week period. During this time, the product will only be available to order once current stocks have been exhausted. Further information on 0845 608 8866.
10 November 2012
Intrinsa (testosterone) patch 300µg no longer has a licence, following the marketing authorisation holder’s decision to cancel it for commercial reasons. The remaining stock has been bought by HFA Healthcare and will be available on a named patient basis from distributors Movianto. The company expects the stock to last for a year.
The name and packaging of Mesren MR (mesalazine; Tillotts Pharma) tablets 400mg is changing and will be called Octasa MR tablets 400mg. Supply of the Mesren branded product will discontinue after 31 December 2012, to be replaced with the Octasa branded product. The appearance and composition of the tablet will remain unchanged.
13 October 2012
Epanutin (phenytoin sodium) capsules are now marketed and distributed by Flynn Pharma, which will distribute the product as Phenytoin Sodium Flynn hard capsules. Pfizer has discontinued the manufacture and marketing of Epanutin capsules.
16 June 2012
Grisol (griseofulvin) spray solution 1% is now available from Transdermal Ltd. Net price: 1 x 20ml, £3.35. Legal category: GSL.
Grisol AF (griseofulvin) spray solution 1% is now available from Transdermal Ltd. Net price: 1 x 20ml, £3.35. Legal category: P.
Pliazon (Merck Serono) cream is now available free of charge to patients undergoing anti-EGFR antibody therapy for metastatic colorectal cancer. The cream, for skin reactions, is available via an order form, which can be obtained by emailing CSC.firstname.lastname@example.org. Legal category: Class I medical device.
5 May 2012
Optive Plus (carmellose sodium 0.5%, glycerin 1%, castor oil 0.25%) eye drops are now available from Allergan. Net price: 1 x 10ml, £7.49. Legal category: medical device.